High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005-2010

Archives of Virology

Volumn 158, Issue 1, 2013, Pages 241-245

  Cho, Han Gil ^b,d   Choi, Jang Hoon ^c   Kim, Woon Ho ^b   Hong, Hae Kun ^b   Yoon, Mi Hye ^b   Jho, Eek Hoon ^d   Kang, Chun ^c   Lim, Young Hee ^a  

^a Korea University   (South Korea)

^b Gyeonggi do Research Institute of Health and Environment   (South Korea)

^c Korea Centers for Disease Control and Prevention   (South Korea)

^d University of Seoul   (South Korea)

Author keywords

Amantadine resistance; Influenza A virus; Phylogenetic analysis

Indexed keywords

INFLUENZA A VIRUS; INFLUENZAVIRUS A;

EID: 84872274347     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1482-9     Document Type: Article

References (18)

1. Englund JA (2002) Antiviral therapy of influenza. Semin Pediatr Infect Dis 13: 120-128.
2. Stöhr K (2002) Influenza-WHO cares. Lancet Infect Dis 2: 517.
3. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RAM, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) Influenza viruses circulating in humans. Science 325: 197-201.
4. Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, Cox N (2002) The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci USA 99: 10748-10752.
5. Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI (2007) Surveillance of resistance to adamantanes among Influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 196: 249-257.
6. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human Influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52: 3284-3292.
7. Lamb RA, Zebedee SL, Richardson CD (1985) Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40: 627-633.
8. Shiraishi K, Mitamura K, Sakai-Tagawa Y, Goto H, Sugaya N, Kawaoka Y (2003) High frequency of resistant viruses harboring different mutations in amantadine-treated children with Influenza. J Infect Dis 188: 57-61.
9. Bright RA, Medina M, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI (2005) Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366: 1175-1181.
10. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI (2006) Adamantane resistance among Influenza A viruses isolated early during the 2005-2006 Influenza season in the United States. JAMA 295: 891-894.
11. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
12. Choi W, Kim S, Lee N, Kwon M, Yang I, Kim M, Cheong S, Kwon D, Lee J, Oh H, Kang C (2009) Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009. Antiviral Res 84: 199-202.
13. Kang S, Yang IS, Lee JY, Park Y, Oh HB, Kang C, Kim KH (2010) Epidemiologic study of human influenza virus infection in South Korea from 1999 to 2007: origin and evolution of A/Fujian/411/2002-like strains. J Clin Microbiol 48: 2177-2185.
14. Zaraket H, Kondo H, Tabet C, Hanna-Wakim R, Suzuki Y, Dbaibo GS, Saito R, Suzuki H (2011) Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon. J Clin Virol 51: 170-174.
15. Saito R, Suzuki Y, Li D, Zaraket H, Sato I, Masaki H, Kawashima T, Hibi S, Sano Y, Shobugawa Y, Oguma T, Suzuki H (2008) Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan. J Infect Dis 197: 630-632; author reply 632-633.
16. Furuse Y, Suzuki A, Shimizu M, Kishi M, Sawayama R, Saito M, Fuji N, Nukiwa N, Oshitani H (2009) Reassortment between amantadine-resistant and -sensitive H1N1 influenza A viruses generated an amantadine-sensitive virus during the 2007-2008 season. J Infect Dis 200: 1766-1773.
17. Furuse Y, Suzuki A, Kamigaki T, Shimizu M, Fuji N, Oshitani H (2009) Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol 47: 841-844.
18. Centers for Disease Control and Prevention (CDC) (2006) High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents-United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep 55: 44-46.